Component
GABA-B receptor subunit 2 / GABBR2
GABA-B receptor subunit 2 / GABBR2. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
A new GABA-B receptor subtype GABA-B R2 does not bind available GABA-B antagonists with measurable potency, GABA-B R1a, R1b and R2 alone do not activate Kir3-type potassium channels efficiently but co-expression yields a robust coupling to activation of Kir3 channels, there is evidence for assembly of heteromeric GABA-B receptors in vivo with the proteins immunoprecipitating and localizing together at dendritic spines, and the heteromeric receptor complexes exhibit a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors and probably represent the predominant native GABA-B receptor.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/gaba-research/9872317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb", "start_char": 0, "end_char": 1620, "text_sha256": "6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb"}
- experimental_model
- Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling
- exposure
- GABA-B R1a, R1b and R2 expressed alone and in combination
- limitations
- A companion study reaching the same conclusion by a different route, including colocalisation at dendritic spines in vivo.
- nutrient_topic
- GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
- organism
- Rat
- plain_language
- Put the two subunits together and the receptor not only works but binds its agonist far better than either part did.
- primary_references
- [gb-p9872317] GABA(B)-receptor subtypes assemble into functional heteromeric complexes. (1998). https://pubmed.ncbi.nlm.nih.gov/9872317/ DOI: 10.1038/25360
- tissue_or_cell_type
- Transfected cells and dendritic spines
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling · source_derived_draft · unverified_draft
### gb-the-pair-binds-better-than-either A new GABA-B receptor subtype GABA-B R2 does not bind available GABA-B antagonists with measurable potency, GABA-B R1a, R1b and R2 alone do not activate Kir3-type potassium channels efficiently but co-expression yields a robust coupling to activation of Kir3 channels, there is evidence for assembly of heteromeric GABA-B receptors in vivo with the proteins immunoprecipitating and localizing together at dendritic spines, and the heteromeric receptor complexes exhibit a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors and probably represent the predominant native GABA-B receptor. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Put the two subunits together and the receptor not only works but binds its agonist far better than either part did. organism: Rat tissue_or_cell_type: Transfected cells and dendritic spines experimental_model: Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling limitations: A companion study reaching the same conclusion by a different route, including colocalisation at dendritic spines in vivo. exposure: GABA-B R1a, R1b and R2 expressed alone and in combination evidence_span: {"source_cache": "artifacts/gaba-research/9872317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb", "start_char": 0, "end_char": 1620, "text_sha256": "6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb"} [gb-p9872317] GABA(B)-receptor subtypes assemble into functional heteromeric complexes. (1998). https://pubmed.ncbi.nlm.nih.gov/9872317/ DOI: 10.1038/25360
Complete structured claim and evidence
Where it participates (unsigned role)
Cells heterologously expressing the cloned DNA encoding the GABA-B R1 protein exhibit high-affinity antagonist-binding sites but produce little of the functional activity expected from studies of endogenous GABA-B receptors in the brain, neither GABA-B R1 nor GABA-B R2 when expressed individually activates GIRK-type potassium channels, however the combination of the two confers robust stimulation of channel activity, both genes are co-expressed in individual neurons and both proteins co-localize in transfected cells, and immunoprecipitation indicates that the two polypeptides associate with each other probably as heterodimers.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/gaba-research/9872315.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c6687fd9eb8b7ebcc0496a2385b0201b02662a5fe8da87a0089650a150f00613", "start_char": 0, "end_char": 1473, "text_sha256": "c6687fd9eb8b7ebcc0496a2385b0201b02662a5fe8da87a0089650a150f00613"}
- experimental_model
- Heterologous expression and immunoprecipitation of two GABA-B polypeptides with potassium channel readout
- exposure
- GABA-B R1 and R2 expressed alone and together, with GIRK-type potassium channel activity as the readout
- limitations
- Heterologous expression. The functional claim rests on channel activation in transfected cells rather than in native tissue.
- nutrient_topic
- GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
- organism
- Rat and human genes
- plain_language
- Two proteins that each do almost nothing on their own make a working receptor only when put together.
- primary_references
- [gb-p9872315] GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. (1998). https://pubmed.ncbi.nlm.nih.gov/9872315/ DOI: 10.1038/25348
- tissue_or_cell_type
- Transfected cells and neurons
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Heterologous expression and immunoprecipitation of two GABA-B polypeptides with potassium channel readout · source_derived_draft · unverified_draft
### gb-neither-half-works-alone Cells heterologously expressing the cloned DNA encoding the GABA-B R1 protein exhibit high-affinity antagonist-binding sites but produce little of the functional activity expected from studies of endogenous GABA-B receptors in the brain, neither GABA-B R1 nor GABA-B R2 when expressed individually activates GIRK-type potassium channels, however the combination of the two confers robust stimulation of channel activity, both genes are co-expressed in individual neurons and both proteins co-localize in transfected cells, and immunoprecipitation indicates that the two polypeptides associate with each other probably as heterodimers. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Two proteins that each do almost nothing on their own make a working receptor only when put together. organism: Rat and human genes tissue_or_cell_type: Transfected cells and neurons experimental_model: Heterologous expression and immunoprecipitation of two GABA-B polypeptides with potassium channel readout limitations: Heterologous expression. The functional claim rests on channel activation in transfected cells rather than in native tissue. exposure: GABA-B R1 and R2 expressed alone and together, with GIRK-type potassium channel activity as the readout evidence_span: {"source_cache": "artifacts/gaba-research/9872315.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c6687fd9eb8b7ebcc0496a2385b0201b02662a5fe8da87a0089650a150f00613", "start_char": 0, "end_char": 1473, "text_sha256": "c6687fd9eb8b7ebcc0496a2385b0201b02662a5fe8da87a0089650a150f00613"} [gb-p9872315] GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. (1998). https://pubmed.ncbi.nlm.nih.gov/9872315/ DOI: 10.1038/25348
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.